![]() |
|
|
Vol. 280, Issue 1, 61-66, 1997
Neuropharmacology Section, Laboratory of Toxicology, National
Institute of Environmental Health Sciences, National Institutes of
Health, Research Triangle Park, North Carolina
Dynorphins (dyn) are a major class of endogenous opioid peptides that
modulate the functions of immune cells. However, the effects of dyn on
the immune functions of glial cells in the central nervous system (CNS)
have not been well characterized. Because nitric oxide (NO) and the
proinflammatory cytokine tumor necrosis factor-
(TNF-
) produced
by glial cells are involved in various physiopathological conditions in
the CNS, this study examined the effects of dyn on the production of NO
and TNF-
from mouse glial cells treated with lipopolysaccharide
(LPS). LPS induced a concentration-dependent increase in the production
of NO or TNF-
from the mouse primary mixed glia cultures. Ultralow
concentrations (10
16-10
12 M) of dynorphin
(dyn) A-(1-8) significantly inhibited the LPS-induced production of NO
or TNF-
. The inhibitory effects of dyn A-(1-8) were not blocked by
nor-binaltorphimine, a selective
opioid receptor antagonist.
U50-488H, a selective
opioid receptor agonist, did not affect the
LPS-induced production of NO or TNF-
. Ultralow concentrations
(10
16-10
12 M) of
des-[Tyr1]-dyn A-(2-17), a nonopioid analog that does
not bind to
opioid receptors, exhibited the same inhibitory effects
as dyn A-(1-17) and dyn A-(1-8). These results suggest that dyn
modulate the immune functions of microglia and/or astrocytes in the
brain and these modulatory effects of dyn are not mediated by classical
opioid receptors.
This article has been cited by other articles:
![]() |
I. Tegeder and G. Geisslinger Opioids As Modulators of Cell Death and Survival--Unraveling Mechanisms and Revealing New Indications Pharmacol. Rev., September 1, 2004; 56(3): 351 - 369. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Liu and J.-S. Hong Role of Microglia in Inflammation-Mediated Neurodegenerative Diseases: Mechanisms and Strategies for Therapeutic Intervention J. Pharmacol. Exp. Ther., January 1, 2003; 304(1): 1 - 7. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Liu, L. Qin, S.-N. Yang, B. C. Wilson, Y. Liu, and J.-S. Hong Femtomolar Concentrations of Dynorphins Protect Rat Mesencephalic Dopaminergic Neurons against Inflammatory Damage J. Pharmacol. Exp. Ther., September 1, 2001; 298(3): 1133 - 1141. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Liu, L. Du, and J.-S. Hong Naloxone Protects Rat Dopaminergic Neurons against Inflammatory Damage through Inhibition of Microglia Activation and Superoxide Generation J. Pharmacol. Exp. Ther., May 1, 2000; 293(2): 607 - 617. [Abstract] [Full Text] |
||||
![]() |
S.-S. Yeh and M. W Schuster Geriatric cachexia: the role of cytokines Am. J. Clinical Nutrition, August 1, 1999; 70(2): 183 - 197. [Abstract] [Full Text] [PDF] |
||||